Saturday, July 11, 2026

Drug profile · INN

ceftizoxime sodium

ceftizoxime sodium (CEFIZOX) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ceftizoxime sodium
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

ceftizoxime sodium (CEFIZOX) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN ceftizoxime sodium
Brand CEFIZOX
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Bacterial penicillin-binding protein inhibitor

Primary target: Bacterial penicillin-binding protein

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amoxicillin Bacterial penicillin-binding protein inhibitor
  2. ampicillin sodium Bacterial penicillin-binding protein inhibitor
  3. ampicillin/ampicillin trihydrate Bacterial penicillin-binding protein inhibitor
  4. cefaclor Bacterial penicillin-binding protein inhibitor
  5. cefadroxil/cefadroxil hemihydrate Bacterial penicillin-binding protein inhibitor
  6. cefazolin sodium Bacterial penicillin-binding protein inhibitor

Frequently asked questions

What is ceftizoxime sodium?

ceftizoxime sodium (CEFIZOX) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for ceftizoxime sodium?

CEFIZOX is a marketed brand name for ceftizoxime sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ceftizoxime sodium?

ceftizoxime sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.